BAXTER INTERNATIONAL INC. Proceeds and Excess Tax Benefit from Share-based Compensation
BAXTER INTERNATIONAL INC. (BAX) reported Proceeds and Excess Tax Benefit from Share-based Compensation of $54.00 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-17.
Discontinued › Notes › Compensation Related Costs
us-gaap:ProceedsAndExcessTaxBenefitFromSharebasedCompensation · last filed 2020-03-17
- BAXTER INTERNATIONAL INC. proceeds and excess tax benefit from share-based compensation for the quarter ending 2016-12-31 was $39.00M, a 50.00% increase year-over-year.
- BAXTER INTERNATIONAL INC. proceeds and excess tax benefit from share-based compensation for the quarter ending 2016-09-30 was $91.00M, a 65.45% increase year-over-year.
- BAXTER INTERNATIONAL INC. proceeds and excess tax benefit from share-based compensation for the quarter ending 2016-06-30 was $96.00M, a 35.21% increase year-over-year.
- BAXTER INTERNATIONAL INC. proceeds and excess tax benefit from share-based compensation for the quarter ending 2016-03-31 was $99.00M, a 106.25% increase year-over-year.
- BAXTER INTERNATIONAL INC. proceeds and excess tax benefit from share-based compensation for fiscal 2019 was $54.00M, a 35.00% increase from fiscal 2018.
- BAXTER INTERNATIONAL INC. proceeds and excess tax benefit from share-based compensation for fiscal 2018 was $40.00M, a 28.57% decline from fiscal 2017.
- BAXTER INTERNATIONAL INC. proceeds and excess tax benefit from share-based compensation for fiscal 2017 was $56.00M, a 82.77% decline from fiscal 2016.
- BAXTER INTERNATIONAL INC. proceeds and excess tax benefit from share-based compensation for fiscal 2016 was $325.00M, a 62.50% increase from fiscal 2015.
| Period end | Proceeds and Excess Tax Benefit from Share-based Compensation 3 month | Proceeds and Excess Tax Benefit from Share-based Compensation 6 month | Proceeds and Excess Tax Benefit from Share-based Compensation 9 month | Proceeds and Excess Tax Benefit from Share-based Compensation 12 month |
|---|---|---|---|---|
| 2019-12-31 | $54.00M 10-K · filed 2020-03-17 | |||
| 2018-12-31 | $40.00M 10-K · filed 2020-03-17 | |||
| 2017-12-31 | $56.00M 10-K · filed 2020-03-17 | |||
| 2016-12-31 | $39.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $130.00M derived: sum of 2 quarters · filed 2017-02-23 | $226.00M derived: sum of 3 quarters · filed 2017-02-23 | $325.00M 10-K · filed 2017-02-23 |
| 2016-09-30 | $91.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $187.00M derived: sum of 2 quarters · filed 2016-11-07 | $286.00M 10-Q · filed 2016-11-07 | $312.00M derived: sum of 4 quarters · filed 2017-02-23 |
| 2016-06-30 | $96.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $195.00M 10-Q · filed 2016-08-04 | $221.00M derived: sum of 3 quarters · filed 2017-02-23 | $276.00M derived: sum of 4 quarters · filed 2017-02-23 |
| 2016-03-31 | $99.00M 10-Q · filed 2016-05-06 | $125.00M derived: sum of 2 quarters · filed 2017-02-23 | $180.00M derived: sum of 3 quarters · filed 2017-02-23 | $251.00M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-12-31 | $26.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $81.00M derived: sum of 2 quarters · filed 2017-02-23 | $152.00M derived: sum of 3 quarters · filed 2017-02-23 | $200.00M 10-K · filed 2017-02-23 |
| 2015-09-30 | $55.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $126.00M derived: sum of 2 quarters · filed 2016-11-07 | $174.00M 10-Q · filed 2016-11-07 | $223.00M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $71.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $119.00M 10-Q · filed 2016-08-04 | $168.00M derived: sum of 3 quarters · filed 2017-02-23 | $239.00M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | $48.00M 10-Q · filed 2016-05-06 | $97.00M derived: sum of 2 quarters · filed 2017-02-23 | $168.00M derived: sum of 3 quarters · filed 2017-02-23 | $279.00M derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | $49.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $120.00M derived: sum of 2 quarters · filed 2017-02-23 | $231.00M derived: sum of 3 quarters · filed 2017-02-23 | $369.00M 10-K · filed 2017-02-23 |
| 2014-09-30 | $71.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $182.00M derived: sum of 2 quarters · filed 2015-11-09 | $320.00M 10-Q · filed 2015-11-09 | $360.00M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $111.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $249.00M 10-Q · filed 2015-08-07 | $289.00M derived: sum of 3 quarters · filed 2016-02-26 | $416.00M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $138.00M 10-Q · filed 2015-05-06 | $178.00M derived: sum of 2 quarters · filed 2016-02-26 | $305.00M derived: sum of 3 quarters · filed 2016-02-26 | $450.00M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $40.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $167.00M derived: sum of 2 quarters · filed 2016-02-26 | $312.00M derived: sum of 3 quarters · filed 2016-02-26 | $508.00M 10-K · filed 2016-02-26 |
| 2013-09-30 | $127.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | $272.00M derived: sum of 2 quarters · filed 2014-10-29 | $468.00M 10-Q · filed 2014-10-29 | $673.00M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | $145.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-30 | $341.00M 10-Q · filed 2014-07-30 | $546.00M derived: sum of 3 quarters · filed 2015-02-26 | $673.00M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | $196.00M 10-Q · filed 2014-04-30 | $401.00M derived: sum of 2 quarters · filed 2015-02-26 | $528.00M derived: sum of 3 quarters · filed 2015-02-26 | $547.00M derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | $205.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $332.00M derived: sum of 2 quarters · filed 2015-02-26 | $351.00M derived: sum of 3 quarters · filed 2015-02-26 | $512.00M 10-K · filed 2015-02-26 |
| 2012-09-30 | $127.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $146.00M derived: sum of 2 quarters · filed 2013-10-30 | $307.00M 10-Q · filed 2013-10-30 | $350.00M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-06-30 | $19.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31 | $180.00M 10-Q · filed 2013-07-31 | $223.00M derived: sum of 3 quarters · filed 2014-02-21 | $324.00M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-03-31 | $161.00M 10-Q · filed 2013-05-01 | $204.00M derived: sum of 2 quarters · filed 2014-02-21 | $305.00M derived: sum of 3 quarters · filed 2014-02-21 | $475.00M derived: sum of 4 quarters · filed 2014-02-21 |
| 2011-12-31 | $43.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $144.00M derived: sum of 2 quarters · filed 2014-02-21 | $314.00M derived: sum of 3 quarters · filed 2014-02-21 | $448.00M 10-K · filed 2014-02-21 |
| 2011-09-30 | $101.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $271.00M derived: sum of 2 quarters · filed 2012-11-01 | $405.00M 10-Q · filed 2012-11-01 | $517.00M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-06-30 | $170.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $304.00M 10-Q · filed 2012-08-02 | $416.00M derived: sum of 3 quarters · filed 2013-02-21 | $450.00M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-03-31 | $134.00M 10-Q · filed 2012-05-03 | $246.00M derived: sum of 2 quarters · filed 2013-02-21 | $280.00M derived: sum of 3 quarters · filed 2013-02-21 | |
| 2010-12-31 | $112.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $146.00M derived: sum of 2 quarters · filed 2013-02-21 | $381.00M 10-K · filed 2013-02-21 | |
| 2010-09-30 | $34.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $269.00M 10-Q · filed 2011-11-02 | ||
| 2010-06-30 | $235.00M 10-Q · filed 2011-08-02 | |||
| 2009-12-31 | $381.00M 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |